DennisLCooperMD

Oncology • Bronx, NY

Hematologic Oncology

Professor of Medicine, Yale University

Join to view full profile

Dr. Cooper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cooper's full profile

Already have an account?

Office
111 E 210th St
Bronx, NY 10467
Phone+1 718-920-4826

Fax+1 732-235-8094

Education & Training

UPMC Medical EducationResidency, Internal Medicine, 1982 - 1983
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
Rush Medical College of Rush University Medical CenterClass of 1979
Yale-New Haven Medical CenterFellowship, Medical Oncology

Certifications & Licensure

NY State Medical License 2022 - 2026
CT State Medical License 1981 - 2025
NJ State Medical License 2015 - 2023
PA State Medical License 1982 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.
Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, Mark Forsberg, Metodi Balev
British Journal of Haematology. 2024-11-01
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database.
John Yan, M Bakri Hammami, John X Wei, Nishi Shah, Mendel Goldfinger
Annals of Hematology. 2024-09-01
A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia.
Steve Kong, Sanjana Nagraj, Dennis L Cooper, Kevin J Ferrick, Lili Zhang
Cardio-Oncology. 2024-08-09

Abstracts/Posters

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up
Dennis Cooper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019